ARS Pharmaceuticals Inc (NASDAQ:SPRY)

6.22
Delayed Data
As of Nov 25
 -0.25 / -3.86%
Today’s Change
2.80
Today|||52-Week Range
7.55
-6.61%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for ARS Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a -19.61% decrease from the last price of 6.22.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Hold stock in ARS Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.47
Sales
$0.00
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.33%
 
 
 
 
 
 
Growthannually 19.14%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.